| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |